Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?
Multidisciplinary insights on helping patients with ADHD during the COVID-19 pandemic, medication abuse, and other factors affecting care.
The discussion on psychiatric diagnoses and descriptive labels continues…
How can looking at the suffering of patients with schizophrenia through a psychodynamic lens help clinicians develop effective interventions and treatment plans?
Malingering is a common challenge for emergency department clinicians, particularly during the pandemic. Here are 3 cases of COVID-19–induced malingering.
Panelists discuss how viloxazine fits into both pediatric and adult ADHD treatment plans, especially as a non-stimulant option for patients with complex cases or concerns about stimulant side effects, while emphasizing flexible dosing and caregiver involvement.
Schizophrenia is one of the most recognized yet least understood chronic brain disorders.
We need policies that make digital therapeutics accessible and acceptable to a broad patient audience. What barriers are there to reaching that goal?
A new poll sought to understand the public’s beliefs about mental health and suicide prevention. Here are the results.
Work takes up one-third of a patient’s life—it is important that we pay attention to it.
How can clinicians distinguish between ordinary grief, depression, and prolonged grief disorder?
Exploring the association between methamphetamine use and the development of psychotic symptoms, such as paranoid delusions, ideas of reference, and auditory hallucinations.
How can we face the current pandemic while addressing the brain health crisis?
How can you best identify and manage pediatric PTSD?
Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.
How can clinicians recognize and acknowledge the injustices often experienced by COVID long-haulers?
Three women describe the massive impact COVID-19 has had on their lives.
An interview with Brendon Stubbs, PhD.
More than half of physicians believe that seeking psychiatric care would jeopardize their employment. What can be done?
A former resident's reflection on burnout, physician PTSD, and their consequences for patient care.
Richard K. Bogan, MD, FCCP, FAASM, and Asim Roy, MD, share take-home messages for the management of narcolepsy.
Beyond the COVID-19-driven shock, we must develop a resilient future in an increasingly uncertain world.
How can mindfulness-based intervention be used as an effective treatment option for psychiatric patients?
An expert shares more about the recent data on NeuroStar advanced TMS. Learn more here.
Evidence indicates that children and adolescents with ADHD have a more than 4-fold increased risk of schizophrenia spectrum and other psychotic disorders in adulthood compared with the general population.
Safety planning by peers is feasible and acceptable to patients, might result in decreased ED visits, and may represent a way of implementing safety plans in rural EDs.
A new digital therapeutic helps patients with psychosis to slow down and manage their fears.
The pandemic has brought into focus treatment barriers, disruption in care, and possibly negative outcomes in the mental health of university students. To better understand the specific challenges of out-of-state students, the authors conducted an anonymous national survey of college psychiatrists.